Anthony P Davenport researcher
Davenport, Anthony P.
VIAF ID: 163076268 (Personal)
Permalink: http://viaf.org/viaf/163076268
Preferred Forms
- 100 0 _ ‡a Anthony P Davenport ‡c researcher
-
-
- 100 1 _ ‡a Davenport, Anthony P.
- 100 1 _ ‡a Davenport, Anthony P.
-
- 100 1 _ ‡a Davenport, Anthony P.
- 100 1 _ ‡a Davenport, Anthony P.
-
4xx's: Alternate Name Forms (1)
Works
Title | Sources |
---|---|
[125I]-PD151242: a selective radioligand for human ETA receptors | |
Immunocytochemical Localization of Receptors Using Light and Confocal Microscopy With Application to the Phenotypic Characterization of Knock-Out Mice | |
Immunocytochemical localization of the urotensin-II receptor, UT, to rat and human tissues: Relevance to function | |
In vitro enzymatic processing of radiolabelled big ET-1 in human kidney | |
In vivo imaging of cardiovascular endothelin receptors using the novel radiolabelled antagonist [18F]-SB209670 and positron emission tomography (microPET). | |
In Vivo Mapping of Vascular Inflammation Using the Translocator Protein Tracer 18F-FEDAA1106. | |
Increased response to big endothelin-1 in atherosclerotic human coronary artery: functional evidence for up-regulation of endothelin-converting enzyme activity in disease. | |
Inotropic action of the puberty hormone kisspeptin in rat, mouse and human: cardiovascular distribution and characteristics of the kisspeptin receptor | |
International Union of Pharmacology. LXXII. Recommendations for trace amine receptor nomenclature | |
Introduction | |
Is urotensin-II the new endothelin? | |
The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledgebase of drug targets and their ligands | |
The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY. | |
The IUPHAR/BPS guide to PHARMACOLOGY in 2022: curating pharmacology for COVID-19, malaria and antibacterials | |
Kisspeptins are novel potent vasoconstrictors in humans, with a discrete localization of their receptor, G protein-coupled receptor 54, to atherosclerosis-prone vessels. | |
LGR5 Activates Noncanonical Wnt Signaling and Inhibits Aldosterone Production in the Human Adrenal | |
Life before birth: effects of cortisol on future cardiovascular and metabolic function. | |
Localization of endothelin-1 (ET-1), ET-2, and ET-3, mouse VIC, and sarafotoxin S6b binding sites in mammalian heart and kidney | |
Localization of endothelin receptors in human uterus throughout the menstrual cycle. | |
Localization of immunoreactive endothelin and proendothelin in the human lung | |
Maternal dexamethasone increases endothelin-1 sensitivity and endothelin a receptor expression in ovine foetal placental arteries | |
Measurement of C-terminal fragment of big endothelin-1: a novel method for assessing the generation of endothelin-1 in humans | |
Modulation of the apelin/APJ system in heart failure and atherosclerosis in man | |
Molecular aspects of atrial natriuretic factor physiology. | |
Myricerone caffeoyl ester (50-235) is a non-peptide antagonist selective for human ETA receptors | |
Neuropeptide B and W: neurotransmitters in an emerging G-protein-coupled receptor system | |
No evidence for a local renin-angiotensin system in liver mitochondria | |
Novel ligands BQ123 and BQ3020 characterize endothelin receptor subtypes ETA and ETB in human kidney | |
Novel Nitric Oxide Donors Reverse Endothelin-1-Mediated Constriction in Human Blood Vessels | |
Novel snake venom ligand dendroaspis natriuretic peptide is selective for natriuretic peptide receptor-A in human heart: downregulation of natriuretic peptide receptor-A in heart failure | |
Octopamine distribution in the larvae and adults of two species of moth, Spodoptera littoralis and Manduca sexta | |
Of mice and men: advances in endothelin research and first antagonist gains FDA approval | |
PD156707: A Potent Antagonist of Endothelin-1 in Human Diseased Coronary Arteries and Vein Grafts | |
Peptide and trace amine orphan receptors: prospects for new therapeutic targets | |
Peptide research protocols : endothelin | |
Pharmacological targeting of apelin impairs glioblastoma growth. | |
Pharmacology of renal endothelin receptors | |
Phosphoramidon inhibition of the in vivo conversion of big endothelin-1 to endothelin-1 in the human forearm. | |
Positron emission tomography of [18F]-big endothelin-1 reveals renal excretion but tissue-specific conversion to [18F]-endothelin-1 in lung and liver | |
Potency of PD155080, an orally active ETA receptor antagonist, determined for human endothelin receptors | |
The Prodomain-bound Form of Bone Morphogenetic Protein 10 Is Biologically Active on Endothelial Cells | |
Quantitative autoradiography reveals higher densities of specific calcitonin-gene-related peptide receptors in small intramyocardial compared with large epicardial coronary arteries | |
Radioligand binding assays and quantitative autoradiography of endothelin receptors | |
Radioligand binding reveals chymase as the predominant enzyme for mediating tissue conversion of angiotensin I in the normal human heart | |
Receptor binding techniques | |
Regional hemodynamic actions of selective corticotropin-releasing factor type 2 receptor ligands in conscious rats | |
Regional heterogeneity in the haemodynamic responses to urotensin II infusion in relation to UT receptor localisation | |
Regulation of vascular reactivity by established and emerging GPCRs | |
Relative contribution of endothelin A and endothelin B receptors to vasoconstriction in small arteries from human heart and brain | |
Screening β-arrestin recruitment for the identification of natural ligands for orphan G-protein-coupled receptors | |
Secretion of endothelin-1 and endothelin-3 by human cultured vascular smooth muscle cells | |
Secretory pathways in endothelin synthesis. | |
Sex-related differences in the concentration of Met-enkephalin-like immunoreactivity in the nervous system of an insect, Schistocerca gregaria, revealed by radioimmunoassay | |
Smooth Muscle Endothelin B Receptors Regulate Blood Pressure but Not Vascular Function or Neointimal Remodeling | |
Somatic mutations in ATP1A1 and CACNA1D underlie a common subtype of adrenal hypertension. | |
Strategy for improved [(11)C]DAA1106 radiosynthesis and in vivo peripheral benzodiazepine receptor imaging using microPET, evaluation of [(11)C]DAA1106. | |
Stress-induced changes in the octopamine levels of insect haemolymph | |
Themed section: endothelin | |
The therapeutic potential of PD156707 and related butenolide endothelin antagonists. | |
Thromboxane receptor density is increased in human cardiovascular disease with evidence for inhibition at therapeutic concentrations by the AT(1) receptor antagonist losartan | |
Tissue-Specific Modulation of Endothelin Receptors in a Rat Model of Hypertension | |
Toxicity of chlordimeform and amitraz to the egyptian cotton leafworm (Spodoptera littoralis) and the tobacco budworm (Heliothis virescens) | |
Translating the human genome: renaissance of cardiovascular receptor pharmacology | |
Triptan-induced contractile (5-HT1B receptor) responses in human cerebral and coronary arteries: relationship to clinical effect | |
The use of quantitative immunocytochemistry (QICC) to measure calbindin D28k-like immunoreactivity in the rat brain | |
Vascular Imaging With 18F-Fluorodeoxyglucose Positron Emission Tomography Is Influenced by Hypoxia | |
Vasoconstrictor activity of novel endothelin peptide, ET-1(1 - 31), in human mammary and coronary arteries in vitro | |
ভূমিকা |